← Back to Search

Specialist Referral: Neurology for Neurology (CATORI Trial)

N/A
Waitlist Available
Research Sponsored by Genentech, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

CATORI Trial Summary

This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indication requiring referral to one of the following specialists: neurologist, ophthalmologist, or oncologist. Eligible patients will have recently (≤6 months) been referred to a specialty care provider and not yet seen a specialist (in addition to meeting the other eligibility criteria). The PPD virtual site can enroll patients from anywhere across the United States. The study will collect data to determine whether a patient was seen by a specialist, diagnosed with a specialized disease, patient characteristics potentially associated with being seen or not seen by a specialist, and the reasons/barriers why a patient was not seen by a specialist through a number of patient surveys.

Eligible Conditions
  • Neurology
  • Eye Doctor
  • Cancer

CATORI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of All Participants Seen by a Specialist for Advanced Care After Primary Care Provider Referral to a Specialist at 12 Months
Percentage of All Participants Seen by a Specialist for Advanced Care After Primary Care Provider Referral to a Specialist at 6 Months
Secondary outcome measures
Percentage of Participants Seen by a Specialist After Primary Care Provider Referral Within Each of the Three Specialist Groups at 12 Months
Percentage of Participants Seen by a Specialist After Primary Care Provider Referral Within Each of the Three Specialist Groups at 6 Months
Percentage of Participants Seen by a Specialist and Treated for Their Disease at 12 Months
+3 more

CATORI Trial Design

3Treatment groups
Experimental Treatment
Group I: Specialist Referral: OphthalmologyExperimental Treatment1 Intervention
Group II: Specialist Referral: OncologyExperimental Treatment1 Intervention
Group III: Specialist Referral: NeurologyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Genentech, Inc.Lead Sponsor
1,540 Previous Clinical Trials
567,815 Total Patients Enrolled
Clinical TrialsStudy DirectorGenentech, Inc.
2,201 Previous Clinical Trials
888,648 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~34 spots leftby Apr 2025